Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease

Neurosci Lett. 2010 Nov 19;485(2):121-4. doi: 10.1016/j.neulet.2010.08.083. Epub 2010 Sep 17.

Abstract

In the last decade, several genes have been linked to Parkinson's disease (PD), including GIGYF2, ATP13A2 and GBA. To explore whether mutations in these genes contribute to development of PD in the Brazilian population, we screened 110 patients with early-onset PD. No clearly pathogenic mutations were identified in ATP13A2 and GIGYF2. In contrast, we identified a significantly higher frequency of known pathogenic mutations in GBA gene among the PD cases (6/110=5.4%) when compared to the control group (0/155) (P=0.0047). Our results strongly support an association between GBA gene mutations and an increased risk of PD. Mutations in GIGYF2 and ATP13A2 do not seem to represent a risk factor to the development of PD in the Brazilian population. Considering the scarcity of studies on GIGYF2, ATP13A2 and GBA mutation frequency in Latin American countries, we present significant data about the contribution of these genes to PD susceptibility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Brazil / ethnology
  • Carrier Proteins / genetics*
  • DNA Mutational Analysis / methods
  • Female
  • Genetic Predisposition to Disease / genetics
  • Glucosylceramidase / genetics*
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / enzymology
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism*
  • Proton-Translocating ATPases / genetics*
  • Risk Factors

Substances

  • ATP13A2 protein, human
  • Carrier Proteins
  • GIGYF2 protein, human
  • Glucosylceramidase
  • Proton-Translocating ATPases